1065 related articles for article (PubMed ID: 17574767)
1. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
Leggett JD; Jessop DS; Fulford AJ
Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
[TBL] [Abstract][Full Text] [Related]
2. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats.
Seale JV; Wood SA; Atkinson HC; Harbuz MS; Lightman SL
J Neuroendocrinol; 2004 Dec; 16(12):989-98. PubMed ID: 15667454
[TBL] [Abstract][Full Text] [Related]
3. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
[TBL] [Abstract][Full Text] [Related]
4. Normal hypothalamo-pituitary-adrenal axis function in a rat model of peripheral neuropathic pain.
Bomholt SF; Mikkelsen JD; Blackburn-Munro G
Brain Res; 2005 May; 1044(2):216-26. PubMed ID: 15885220
[TBL] [Abstract][Full Text] [Related]
5. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
6. Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.
Finn DP; Hudson AL; Kinoshita H; Coventry TL; Jessop DS; Nutt DJ; Harbuz MS
J Psychopharmacol; 2004 Mar; 18(1):47-53. PubMed ID: 15107184
[TBL] [Abstract][Full Text] [Related]
7. Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion.
Spiga F; Harrison LR; Wood SA; Atkinson HC; MacSweeney CP; Thomson F; Craighead M; Grassie M; Lightman SL
J Neuroendocrinol; 2007 Nov; 19(11):891-900. PubMed ID: 17927667
[TBL] [Abstract][Full Text] [Related]
8. Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.
Leggett JD; Dawe KL; Jessop DS; Fulford AJ
J Neuroendocrinol; 2009 Nov; 21(11):888-97. PubMed ID: 19732291
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two repeated restraint stress paradigms on hypothalamic-pituitary-adrenal axis habituation, gonadal status and central neuropeptide expression in adult male rats.
Gray M; Bingham B; Viau V
J Neuroendocrinol; 2010 Feb; 22(2):92-101. PubMed ID: 20002965
[TBL] [Abstract][Full Text] [Related]
10. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
11. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
12. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus.
Lund TD; Munson DJ; Haldy ME; Handa RJ
J Neuroendocrinol; 2004 Mar; 16(3):272-8. PubMed ID: 15049858
[TBL] [Abstract][Full Text] [Related]
13. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
[TBL] [Abstract][Full Text] [Related]
14. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats.
Seale JV; Wood SA; Atkinson HC; Bate E; Lightman SL; Ingram CD; Jessop DS; Harbuz MS
J Neuroendocrinol; 2004 Jun; 16(6):516-24. PubMed ID: 15189326
[TBL] [Abstract][Full Text] [Related]
15. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat.
Rotllant D; Armario A
Neuroscience; 2005; 130(2):427-34. PubMed ID: 15664699
[TBL] [Abstract][Full Text] [Related]
16. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats.
Greisen MH; Bolwig TG; Wörtwein G
Behav Brain Res; 2005 Jun; 161(2):204-12. PubMed ID: 15922046
[TBL] [Abstract][Full Text] [Related]
18. Long-term voluntary exercise and the mouse hypothalamic-pituitary-adrenocortical axis: impact of concurrent treatment with the antidepressant drug tianeptine.
Droste SK; Schweizer MC; Ulbricht S; Reul JM
J Neuroendocrinol; 2006 Dec; 18(12):915-25. PubMed ID: 17076767
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity.
Spiga F; Harrison LR; Wood S; Knight DM; MacSweeney CP; Thomson F; Craighead M; Lightman SL
J Endocrinol; 2009 Mar; 200(3):273-83. PubMed ID: 19008333
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
